Valuation Asymchem Laboratories (Tianjin) Co., Ltd.

Stocks

End-of-day quote Shenzhen S.E. 23/10/2026			5-day change	1st Jan Change
146.22 ^CNY	+4.70%		-1.93%	+57.34%

10-23	Asymchem Laboratories Tianjin Posts Higher Q3 Adjusted Attributable Profit; Revenue Up	MT
10-22	Asymchem Laboratories Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	111,228	52,704	41,387	26,238	32,605	51,366	-	-
Change	-	-52.62%	-21.47%	-36.6%	24.27%	57.54%	-	-
Enterprise Value (EV) ¹	105,383	47,524	34,318	20,491	26,337	47,088	47,716	48,476
Change	-	-54.9%	-27.79%	-40.29%	28.53%	78.79%	1.33%	1.59%
P/E	99.1x	16.4x	18.5x	28.3x	29.4x	39.3x	29.7x	23.1x
PBR	9.07x	3.5x	2.46x	1.66x	1.9x	2.82x	2.63x	2.42x
PEG	-	0x	-0.6x	-0.5x	1.7x	2.2x	0.9x	0.8x
Capitalization / Revenue	24x	5.15x	5.29x	4.52x	4.89x	6.39x	5.2x	4.25x
EV / Revenue	22.7x	4.65x	4.39x	3.53x	3.95x	5.86x	4.83x	4.01x
EV / EBITDA	75.3x	13.6x	11.2x	16.1x	15.1x	22.5x	18.5x	15.2x
EV / EBIT	88.4x	15.2x	13.3x	19x	22.5x	30.5x	24x	18.8x
EV / FCF	-68.1x	41.8x	14.6x	164x	192x	-49.4x	-631x	68.8x
FCF Yield	-1.47%	2.39%	6.84%	0.61%	0.52%	-2.02%	-0.16%	1.45%
Dividend per Share ²	0.5714	1.8	1.8	1.1	1.3	1.264	1.804	2.167
Rate of return	0.18%	1.22%	1.55%	1.45%	1.4%	0.86%	1.23%	1.48%
EPS ²	3.136	9	6.26	2.69	3.16	3.725	4.932	6.34
Distribution rate	18.2%	20%	28.8%	40.9%	41.1%	33.9%	36.6%	34.2%
Net sales ¹	4,639	10,230	7,825	5,805	6,670	8,038	9,873	12,087
EBITDA ¹	1,399	3,498	3,058	1,274	1,744	2,097	2,584	3,194
EBIT ¹	1,192	3,136	2,571	1,079	1,169	1,542	1,991	2,580
Net income ¹	1,069	3,302	2,269	949	1,133	1,346	1,779	2,286
Net Debt ¹	-5,846	-5,180	-7,069	-5,747	-6,268	-4,278	-3,649	-2,889
Reference price ²	310.71	148.00	116.10	76.09	92.93	146.22	146.22	146.22
Nbr of stocks (in thousands)	368,307	364,755	364,426	354,879	359,442	359,630	-	-
Announcement Date	30/03/22	30/03/23	28/03/24	28/03/25	30/03/26	-	-	-

¹CNY in Million²CNY

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ASYMCHEM LABORATORIES (TIANJIN) CO., LTD.	39.25x	5.86x	22.45x	0.86%	7.7B
ELI LILLY AND COMPANY	36.74x	13.1x	27.8x	0.54%	1,135B
JOHNSON & JOHNSON	38.61x	6.5x	18.29x	2.02%	636B
ABBVIE INC.	36.46x	8.38x	17.29x	2.41%	505B
ROCHE HOLDING AG	20.87x	5.11x	12.73x	2.56%	378B
MERCK & CO., INC.	105.89x	5.92x	25.41x	2.34%	358B
NOVARTIS AG	21.76x	5.67x	13.94x	2.81%	295B
ASTRAZENECA PLC	22.42x	4.53x	12.96x	1.95%	266B
AMGEN INC.	27.87x	7.16x	12.81x	2.3%	237B
GILEAD SCIENCES, INC.	-45.48x	6.98x	27.06x	2.11%	193B
Average	30.44x	6.92x	19.07x	1.99%	401.2B
Weighted average by Cap.	35.15x	8.29x	20.40x	1.8%